{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:28:09Z","timestamp":1793744889448,"version":"4.6.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gore.2026.102209","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:34:15Z","timestamp":1789540455000},"page":"102209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Successful treatment of recurrent epithelioid trophoblastic tumor (ETT) with pembrolizumab after pembrolizumab: A case report and review of literature in treatment of ETT"],"prefix":"10.1016","volume":"67","author":[{"given":"Sarah J.","family":"Mokma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alnaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gore.2026.102209_bb0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000533972","article-title":"Immunotherapy for gestational trophoblastic neoplasia: a new paradigm","volume":"89","author":"Baas","year":"2023","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.gore.2026.102209_bb0010","article-title":"Pembrolizumab in gestational trophoblastic neoplasia: systematic review and meta-analysis with sub-group analysis of potential prognostic factors","volume":"80","author":"Barcellos","year":"2025","journal-title":"Clinics"},{"key":"10.1016\/j.gore.2026.102209_bb0015","article-title":"An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab","volume":"37","author":"Bell","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.gore.2026.102209_bb0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.mpdhp.2010.08.002","article-title":"Gestational trophoblastic disease: histopathological diagnosis in the molecular era","volume":"16","author":"Buza","year":"2010","journal-title":"Diagn. Histopathol."},{"key":"10.1016\/j.gore.2026.102209_bb0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2019.08.024","article-title":"Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia","volume":"121","author":"Choi","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.gore.2026.102209_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2018.11.015","article-title":"Management and prognostic factors of epithelioid trophoblastic tumors: results from the international society for the study of trophoblastic diseases database","volume":"152","author":"Frijstein","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"10110","key":"10.1016\/j.gore.2026.102209_bb0035","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gore.2026.102209_bb0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2016.10.024","article-title":"Placental site trophoblastic tumors and epithelioid trophoblastic tumors: biology, natural history, and treatment modalities","volume":"144","author":"Horowitz","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"27","key":"10.1016\/j.gore.2026.102209_bb0045","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1200\/JCO.2017.74.4052","article-title":"Complete serologic response to pembrolizumab in a woman with chemoresistant metastatic choriocarcinoma","volume":"35","author":"Huang","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.gore.2026.102209_bb0055","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.3390\/curroncol28060446","article-title":"Epithelioid trophoblastic tumor: a case with genetic linkage to a child born over seventeen years prior, successfully treated with surgery and pembrolizumab","volume":"28","author":"Pisani","year":"2021","journal-title":"Curr. Oncol."},{"issue":"11","key":"10.1016\/j.gore.2026.102209_bb0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00000478-199811000-00010","article-title":"Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma","volume":"22","author":"Shih","year":"1998","journal-title":"The Am. J. Surg. Pathol."},{"key":"10.1016\/j.gore.2026.102209_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101974","article-title":"Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study","volume":"59","author":"Wang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.gore.2026.102209_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7150\/jca.28134","article-title":"Epithelioid trophoblastic tumors: treatments, outcomes, and potential therapeutic targets","volume":"10","author":"Yang","year":"2018","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.gore.2026.102209_bb0075","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/IGC.0b013e31829ea023","article-title":"Epithelioid trophoblastic tumor","volume":"23","author":"Zhang","year":"2013","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235257892600189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235257892600189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:02:52Z","timestamp":1793743372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235257892600189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":14,"alternative-id":["S235257892600189X"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102209","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of recurrent epithelioid trophoblastic tumor (ETT) with pembrolizumab after pembrolizumab: A case report and review of literature in treatment of ETT","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102209"}}